Health
Study finds two drugs capable of slowing bone marrow cancer progression – News-Medical.Net
Primary myelofibrosis (PMF), a relatively rare but painful type of bone marrow cancer, disrupts the body’s normal production of blood cells by causing extensive…
Primary myelofibrosis (PMF), a relatively rare but painful type of bone marrow cancer, disrupts the body’s normal production of blood cells by causing extensive scarring in the bone marrow. Regrettably, few treatment options are available, with most of them being palliative in nature. The only curative treatment is a stem cell transplant, for which few patients are eligible.
A new study by researchers at Boston University School of Medicine (BUSM) led by corresponding author Katya Ravid, DSc, has…
-
General14 hours agoBunbury man Stanley J Clemons sentenced for shooting neighbour’s dog
-
Business16 hours agoThese 4 ASX mining stocks are rocketing as the rare earths boom intensifies
-
Noosa News16 hours agoLung cancer researchers identify ‘breakthrough’ patterns predictive of treatment success
-
General23 hours agoAustralia solved civilisation’s problems